OBJECTIVE: A wide variety of antiangiogenic agents have been developed for the treatment
of neoplasms. Imaging studies play an important role in assessing the effects of these treatments.
CONCLUSION: This review article introduces radiologists to features of these therapies and the most important clinical and preclinical imaging techniques for evaluating antiangiogenic agents.